EKO International Inc (EKNL)

[JLPTNG]

$EKNL – On Xtreme Alert for Key Major Updates, ready to rocket towards $2+

Markets will be closed again today due to Hurricane Sandy, but we will be going full steam with EKNL showing its HUGE potential for Mega Gains. In fact, we will continue to profile EKNL well into November.

EKNL’s buzz is getting real crazy and is primed for a MAJOR breakout when Markets open on Wednesday. Be sure to stay tuned for MAJOR updates to be unleashed by the company and MONSTER contracts coming out from the 13th annual medical conference last weekend

EKNL is definitely shaping up to be the BEST play of 2012.

EKNL soared to another all time high on Friday and hitting an all time high price of $0.775.

Technicals are screaming a MAJOR BULLISH BREAKOUT with a confirmed long term GOLDEN CROSS already established.

We have seen how golden crosses can breakout prices big time, in fact our other monster medical company Lifevantage (LFVN), which interesting enough announced a share buy back as well as recently uplisted to Nasdaq soared big time when a golden cross hit.

What makes LFVN and EKNL monster plays are from key similarities.

1) No dilution or insiders selling any time soon and especially at these super low prices. In fact, this leads to our second key similarity,

“Upon the achievement of a positive income statement and the repayment of its liabilities, the Company intends to initiate a program to buy-back common shares on the open market.”

2) Share buyback in effect. Definitely the goal here is to move prices up to proper valuations and big boards like Nasdaq requirements. We also got confirmation with recent announcement selecting MaloneBailey LLP, Certified Public Accounting Firm for appointment as auditors of the Company.

3) Super Low float. With only 5.5 Million active float (shares available at the DTC for trading), EKNL‘s share inventory is drying up super fast, and this is already triggering a MAJOR BULLISH BREAKOUT.

LFVN traded only pennies like EKNL and soared to over $3 per share shortly after their golden cross formation shown below.

Investors can definitely see the same pattern here with EKNL and is following in the exact same path as NASDAQ listed Lifevantage (L$VN)




You bet, there will be many more eyes on this play and also institutional groups now eying our near term price target of $2.00 per share. The potential here is insane with more than triple gains at current levels in the cards



Of course what really stands EKNL apart from everyone else is the relationships and key connections it has build so far.



EKNL released monster news announcing EKO’s Dr. Ziemer of NeuroVasc Medical Inc. and NCI, distributor of Neurometrix (NASDAQ:NURO)’s NC-Stat DPN check device are now available in 100 of WalMart-Canada stores.”


Perry Mayer BSc, MB, Bch, BAO, CCFPDr. Paul Ziemer, world renowned for his expertise in the medical field joined the team at EKNL.



EKNL launched first of many Clinics starting to treat patients with their FDA approved FREMS technology that was also presented at the 13th annual Medical this weekend!



Also, Dr. Ziemer teamed up with Dr. Snow of Neurometrix, a NASDAQ Listed company (NURO) for exclusive hands on demonstration of their testing unit at the show.

No doubt, these are MONSTER updates that are turning a lot of heads, and institutional investors now eying that multi-dollar target level.

These updates already give EKNL HUGE valuation and potential…

…BUT, IT IS WHAT’S STILL TO BE UNLEASHED BY EKNL THAT WILL NOT ONLY BE MIND ‘BLOWING’ IT WILL PROPEL EKNL PRICES ’SKY HIGH’ AND INTO RECORD TERRITORY

With an active float of only 5.5 Million shares and insiders not selling a single share, share inventory continues to dry up super quick making EKNL prices to move fast and furious towards higher levels.

ABOUT EKO INTERNATIONAL

EKO International Corp. is a holding company focused on growth through acquisition. Each acquisition must have substantial growth potential and is expected to add assets and/or cash-flow to the consolidated financial statements of the Company. The Company is willing to examine a variety of proposed target businesses and if interested, will negotiate terms and conditions of purchase favorable to itself.